2006
DOI: 10.1016/j.watres.2006.06.039
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

44
319
4
26

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 664 publications
(393 citation statements)
references
References 23 publications
44
319
4
26
Order By: Relevance
“…Background concentrations of pharmaceuticals were considered negligible as compared to the spiked concentrations based on reported values in wastewater influents (e.g. Joss et al ., 2005; Nakada et al ., 2006) and previous characterization of Ann Arbor WWTP influent (Stadler et al ., 2014). Quantification was performed using a matrix‐matched calibration curve (Fig.…”
Section: Methodsmentioning
confidence: 83%
See 1 more Smart Citation
“…Background concentrations of pharmaceuticals were considered negligible as compared to the spiked concentrations based on reported values in wastewater influents (e.g. Joss et al ., 2005; Nakada et al ., 2006) and previous characterization of Ann Arbor WWTP influent (Stadler et al ., 2014). Quantification was performed using a matrix‐matched calibration curve (Fig.…”
Section: Methodsmentioning
confidence: 83%
“…In addition to conventional pollutants, however, thousands of pharmaceuticals are excreted by humans in intact and metabolized forms, reaching WWTPs before being released into the environment (Kolpin et al ., 2002). The ability of the microbes in WWTPs to biotransform these chemicals is an area of great interest (Carballa et al ., 2004; Castiglioni et al ., 2005; Nakada et al ., 2006; Kasprzyk‐Hordern et al ., 2009). Substantial research has advanced our knowledge of pharmaceutical biotransformation pathways (Ellis et al ., 2006) and the transformation products formed during treatment (Kern et al ., 2010).…”
Section: Introductionmentioning
confidence: 99%
“…In the present study, the specic TP removal rates varied between 0.81 and 1.07 mg per mg chl a per day, which are higher than the values (0.2-0.52 mg per mg chl a per day) reported by Aslan and Kapdan. 21 In addition, the specic TN removal rates (12.13-17.53 mg per mg chl a per day) were also found to be signicantly higher than the specic NH 4 -N removal rates (peak value: 3.0 mg per mg chl a per day) in which NH 4 Cl was used as the nitrogen source. 21 The observed high specic TP and TN removal rates in the present study are due to the low initial chl a concentration (0.05 mg L À1 ), much lower than the value (3.5 mg L À1 ) reported by Aslan and Kapdan.…”
Section: Removal Of Nutrientsmentioning
confidence: 95%
“…[1][2][3][4] Thus discharge of untreated wastewater should be avoided as it could pose risks to the environment and public health. In many countries, domestic wastewater has oen been treated by various types of conventional wastewater treatment technologies such as activated sludge process and oxidation ditch by making use of microbial processes.…”
Section: Introductionmentioning
confidence: 99%
“…Because conventional wastewater treatment processes are not specifically designed for the effective removal of pharmaceuticals, the secondary effluent and the sludge of wastewater treatment plants (WWTPs) have been proven to be an important pollution source of pharmaceuticals (Nakada et al, 2006;Vieno et al, 2007). Nowadays, serious concerns have been raised regarding the occurrence of pharmaceuticals in the environment due to an increasing reuse of wastewater effluent and excess sludge (e.g., landscape irrigation, crop irrigation, biofertilizer) (Sabourin et al, 2012;Wu et al, 2012).…”
Section: Introductionmentioning
confidence: 99%